The inhibition of microphtalmia-associated transcription factor (MITF), a master regulator of melanocyte differentiation, increased the tumorigenic potential of melanoma cells, concomitantly with an upregulation of stem cell markers Oct4 and Nanog [264]. The gene discussed is MITF; the disease is melanoma.